Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD3 agon
Welcome,
Profile
Billing
Logout
Companies
Products
Products
Diseases
Trials
News
1
2
3
4
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Blincyto
(blinatumomab) / Astellas, Amgen
Columvi
(glofitamab-gxbm) / Roche
Lunsumio
(mosunetuzumab-axgb) / Roche
Tecvayli
(teclistamab-cqyv) / Genmab, J&J
Epkinly
(epcoritamab-bysp) / Genmab, AbbVie
Elrexfio
(elranatamab-bcmm) / Pfizer
Talvey
(talquetamab-tgvs) / J&J
Removab
(catumaxomab) / NeoPharm, Trion Pharma
Kimmtrak
(tebentafusp-tebn) / Immunocore
linvoseltamab
(REGN5458) / Regeneron, Sanofi
Imdelltra
(tarlatamab-dlle) / Amgen
Ordspono
(odronextamab) / Regeneron
ABBV-383 IV
/ AbbVie
flotetuzumab
(MGD006) / MacroGenics
obrixtamig
(BI 764532) / Boehringer Ingelheim
activated CIK and bispecific antibody
/ Benhealth Biopharma
cevostamab
(RG6160) / Roche
Undisclosed HER2Bi-armed ATC
/ TransTarget, Barbara Ann Karmanos Cancer Institute
emfizatamab
(GNC-038) / Biokin Pharma
AZD0486
/ AstraZeneca
cibisatamab
(RG7802) / Roche
imvotamab
(IGM-2323) / IGM Biosciences
nebratamig
(GNC-035) / Biokin Pharma
AMG 211
/ Amgen
M701
/ YZY Biopharma
ONO-4685
/ Ono Pharma
alnuctamab
(CC-93269) / BMS
ubamatamab
(REGN4018) / Regeneron
xaluritamig
(AMG 509) / Amgen
CC-1
/ University Hospital Tuebingen
ERY974
/ Roche
JNJ-8343
/ J&J
JNJ-8543
/ J&J
MK-1045
/ Merck (MSD)
NG-641
/ Akamis Bio
QLS31905
/ Qilu Pharma
acapatamab
(AMG 160) / Amgen, BeiGene
mipletamig
(APVO436) / Aptevo Therap
pavurutamab
(AMG 701) / Amgen
plamotamab
(XmAb13676) / Xencor
rezetamig
(JNJ-8780) / J&J
vixtimotamab
(AMV564) / Affimed
vonsetamig
(REGN5459) / Regeneron
A-319
/ ITabMed
A-337
/ ITabMed
AFM11
/ Affimed
BI 765049
/ Boehringer Ingelheim
BNT142
/ BioNTech
BS006
/ Wuhan Binhui Biotech
CLN-978
/ Cullinan Therap
1
2
3
4
»
